SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (443)12/26/1997 10:24:00 PM
From: Brander  Read Replies (1) of 834
 
Mr Wexler, this statement: "It is 100% certain that Novastan will not be approved as an alternative for heparin. " Is 1000 % irresponsible, misleading, and false. It would not be this far with the FDA, if it were 100% certain. They have looked at the clinical information, and they have the background to understand the data, unlike you, a CPA, or so you say. I am sure the the FDA, TXB, and SEC would not enjoy reading such slander posted on a public forum.

Brad
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News